First Time Loading...

Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.628 DKK 11.35% Market Closed
Updated: May 9, 2024

Intrinsic Value

BIOPOR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. [ Read More ]

The intrinsic value of one BIOPOR stock under the Base Case scenario is 1.47 DKK. Compared to the current market price of 1.628 DKK, Bioporto A/S is Overvalued by 10%.

Key Points:
BIOPOR Intrinsic Value
Base Case
1.47 DKK
Overvaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bioporto A/S

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BIOPOR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Bioporto A/S

Provide an overview of the primary business activities
of Bioporto A/S.

What unique competitive advantages
does Bioporto A/S hold over its rivals?

What risks and challenges
does Bioporto A/S face in the near future?

Summarize the latest earnings call
of Bioporto A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioporto A/S.

Provide P/S
for Bioporto A/S.

Provide P/E
for Bioporto A/S.

Provide P/OCF
for Bioporto A/S.

Provide P/FCFE
for Bioporto A/S.

Provide P/B
for Bioporto A/S.

Provide EV/S
for Bioporto A/S.

Provide EV/GP
for Bioporto A/S.

Provide EV/EBITDA
for Bioporto A/S.

Provide EV/EBIT
for Bioporto A/S.

Provide EV/OCF
for Bioporto A/S.

Provide EV/FCFF
for Bioporto A/S.

Provide EV/IC
for Bioporto A/S.

Show me price targets
for Bioporto A/S made by professional analysts.

What are the Revenue projections
for Bioporto A/S?

How accurate were the past Revenue estimates
for Bioporto A/S?

What are the Net Income projections
for Bioporto A/S?

How accurate were the past Net Income estimates
for Bioporto A/S?

What are the EPS projections
for Bioporto A/S?

How accurate were the past EPS estimates
for Bioporto A/S?

What are the EBIT projections
for Bioporto A/S?

How accurate were the past EBIT estimates
for Bioporto A/S?

Compare the revenue forecasts
for Bioporto A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bioporto A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioporto A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioporto A/S compared to its peers.

Compare the P/E ratios
of Bioporto A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioporto A/S with its peers.

Analyze the financial leverage
of Bioporto A/S compared to its main competitors.

Show all profitability ratios
for Bioporto A/S.

Provide ROE
for Bioporto A/S.

Provide ROA
for Bioporto A/S.

Provide ROIC
for Bioporto A/S.

Provide ROCE
for Bioporto A/S.

Provide Gross Margin
for Bioporto A/S.

Provide Operating Margin
for Bioporto A/S.

Provide Net Margin
for Bioporto A/S.

Provide FCF Margin
for Bioporto A/S.

Show all solvency ratios
for Bioporto A/S.

Provide D/E Ratio
for Bioporto A/S.

Provide D/A Ratio
for Bioporto A/S.

Provide Interest Coverage Ratio
for Bioporto A/S.

Provide Altman Z-Score Ratio
for Bioporto A/S.

Provide Quick Ratio
for Bioporto A/S.

Provide Current Ratio
for Bioporto A/S.

Provide Cash Ratio
for Bioporto A/S.

What is the historical Revenue growth
over the last 5 years for Bioporto A/S?

What is the historical Net Income growth
over the last 5 years for Bioporto A/S?

What is the current Free Cash Flow
of Bioporto A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioporto A/S.

Financials

Balance Sheet Decomposition
Bioporto A/S

Current Assets 82.3m
Cash & Short-Term Investments 66.4m
Receivables 10.4m
Other Current Assets 5.5m
Non-Current Assets 7.5m
Long-Term Investments 2.2m
PP&E 2.2m
Intangibles 457k
Other Non-Current Assets 2.7m
Current Liabilities 25.4m
Accounts Payable 6.9m
Other Current Liabilities 18.5m
Non-Current Liabilities 4.3m
Long-Term Debt 4.3m
Efficiency

Earnings Waterfall
Bioporto A/S

Revenue
31m DKK
Cost of Revenue
-10.8m DKK
Gross Profit
20.2m DKK
Operating Expenses
-80.3m DKK
Operating Income
-60.2m DKK
Other Expenses
3.8m DKK
Net Income
-56.3m DKK

Free Cash Flow Analysis
Bioporto A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BIOPOR Profitability Score
Profitability Due Diligence

Bioporto A/S's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
25/100
Profitability
Score

Bioporto A/S's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

BIOPOR Solvency Score
Solvency Due Diligence

Bioporto A/S's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
71/100
Solvency
Score

Bioporto A/S's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOPOR Price Targets Summary
Bioporto A/S

Wall Street analysts forecast BIOPOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOPOR is 5.1 DKK with a low forecast of 5.05 DKK and a high forecast of 5.25 DKK.

Lowest
Price Target
5.05 DKK
210% Upside
Average
Price Target
5.1 DKK
213% Upside
Highest
Price Target
5.25 DKK
222% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

BIOPOR Price
Bioporto A/S

1M 1M
+29%
6M 6M
-10%
1Y 1Y
+2%
3Y 3Y
-59%
5Y 5Y
-58%
10Y 10Y
-37%
Annual Price Range
1.628
52w Low
1.076
52w High
2.965
Price Metrics
Average Annual Return -4.04%
Standard Deviation of Annual Returns 45.86%
Max Drawdown -86%
Shares Statistics
Market Capitalization 618.1m DKK
Shares Outstanding 379 656 992
Percentage of Shares Shorted
N/A

BIOPOR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Bioporto A/S Logo
Bioporto A/S

Country

Denmark

Industry

Biotechnology

Market Cap

618.1m DKK

Dividend Yield

0%

Description

Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.

Contact

Hellerup
Tuborg Havnevej 15, St.
+4545290000.0
http://www.bioporto.com/

IPO

1985-01-02

Employees

29

Officers

CEO & Director
Mr. Peter Morch Eriksen B.B.A., BBA
Chief Scientific Officer
Prof. Lars Otto Uttenthal
VP of Global Marketing & US Commercialization
Ms. Jennifer Zonderman
Executive VP of Strategic Partnerships and GM of EMEA & APAC
Mr. Nis Kruse

See Also

Discover More
What is the Intrinsic Value of one BIOPOR stock?

The intrinsic value of one BIOPOR stock under the Base Case scenario is 1.47 DKK.

Is BIOPOR stock undervalued or overvalued?

Compared to the current market price of 1.628 DKK, Bioporto A/S is Overvalued by 10%.